Grants / Department of Defense / Defense Health Agency Contracting Activity - DHACA

HT942525RCRPRCDA: DoD Rare Cancers, Resource and Community Development Award

Closed Closed October 6, 2025 Opportunity HT942525RCRPRCDA ☆ Save

This grant is closed. A newer notice from the same program is open now: DoW Breast Cancer, Clinical Research Extension Award (HT942526BCRPCREA2). Status: Closes November 18, 2026 (11 days left). It is in our archive of Defense Health Agency Contracting Activity - DHACA notices from 2025.

• Total funding$5.6 million
• Expected awards5
• Cost sharingNot required
• Funding typeGrant

Key dates

Who can apply

This opportunity was open to any type of organization.

• Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

• Most of the program's money (59% over five years) went to colleges and universities.
• No cost sharing or match is required.

What the grant funds

Summary: The fiscal year 2025 (FY25) Rare Cancers Research Program (RCRP) Resource and Community Development Award (RCDA) supports the development of research resources and clinical or preclinical data sets that will advance the field of rare cancers research and ultimately improve outcomes for individuals with rare cancers. Major gaps to be filled by this funding opportunity include: · Lack of research and clinical resources, including patient tissues, cell, and tumor models. · Lack of communication and dissemination strategies within scientific and patient communities for sharing rare cancers research and clinical findings. · Lack of infrastructure for sharing data and other resources. · Lack of therapeutics and mechanistic research to inform treatment development. Distinctive Features: · Engagement and partnerships with Patient Advocates must be integrated into the project from development of the research question through the execution of the study. · Community building and enhancement are key components. · Dissemination and sustainability of the platform for scientific and/or clinical, and patient community must be described. · Preliminary data not required but may be included to address feasibility. Funding Details: (New for FY25) Funding limits are now listed as total cost limits, which is the combination of both direct and indirect costs.

Category: Science and Technology and other Research and Development.

Applying now

This notice no longer takes applications. Apply under the newer notice, HT942526BCRPCREA2, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.